SCHEMBL8947091

SCHEMBL8947091

Cc1cc(/N=N/c2ccc(S(=O)(=O)O)c3ccccc23)c(O)c2ccccc12

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.71
CTRB1 P17538 1/20 0.65
THRB P10828 2/20 0.61
MEN1 O00255 2/20 0.54
KMT2A Q03164 2/20 0.54
TDP1 Q9NUW8 1/20 0.54
SENP2 Q9HC62 5/20 0.49
SUMO2 P61956 4/20 0.49
SUMO1 P63165 4/20 0.49
SENP7 Q9BQF6 4/20 0.49
SENP1 Q9P0U3 4/20 0.49
MPL P40238 3/20 0.49
SENP3 Q9H4L4 3/20 0.49
CTRC Q99895 1/20 0.49
PHLPP2 Q6ZVD8 1/20 0.47
ATIC P31939 2/20 0.46
NSD2 O96028 2/20 0.46
POLB P06746 1/20 0.46
IDE P14735 1/20 0.46
DUSP3 P51452 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
E122 SCHEMBL345295 0.89 CYP1A2 (0.78) CYP1A2CTRB1THRBMEN1KMT2A
E122 SCHEMBL110093 0.89 CYP1A2 (0.78) CYP1A2CTRB1THRBMEN1KMT2A
E122 SCHEMBL185359 0.87 CYP1A2 (0.76) CYP1A2CTRB1THRBMEN1KMT2A
E122 SCHEMBL4806652 0.87 CYP1A2 (0.76) CYP1A2CTRB1THRBMEN1KMT2A
E122 SCHEMBL185360 0.87 CYP1A2 (0.76) CYP1A2CTRB1THRBMEN1KMT2A
SCHEMBL6580682 0.84 CYP1A2 (0.71) CYP1A2CTRB1THRBMEN1KMT2A
E122 SCHEMBL4806638 0.83 THRB (0.90) CYP1A2CTRB1THRBMEN1KMT2A
E122 SCHEMBL3208444 0.83 THRB (0.90) CYP1A2CTRB1THRBMEN1KMT2A
SCHEMBL14418378 0.82 CYP1A2 (0.60) CYP1A2CTRB1THRBMEN1KMT2A
SCHEMBL626036 0.81 CYP1A2 (0.66) CYP1A2CTRB1THRBMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9504637-B2 Coloring agents and methods of use thereof LIVING PROOF, INC. (US) 2016-11-29 US disclosed
US-20160106648-A1 COLORING AGENTS AND METHODS OF USE THEREOF LIVING PROOF, INC. (US) 2016-04-21 US disclosed
US-9248086-B2 Coloring agents and methods of use thereof LIVING PROOF, INC. (US) 2016-02-02 US disclosed
US-20150174026-A1 COLORING AGENTS AND METHODS OF USE THEREOF LIVING PROOF, INC. 2015-06-25 US disclosed
US-8932370-B2 Coloring agents and methods of use thereof LIVING PROOF, INC. (US) 2015-01-13 US disclosed
US-20140326269-A1 COLORING AGENTS AND METHODS OF USE THEREOF LIVING PROOF, INC. 2014-11-06 US disclosed
US-8758451-B2 Coloring agents and methods of use thereof LIVING PROOF, INC. (US) 2014-06-24 US disclosed
US-20140013520-A1 COLORING AGENTS AND METHODS OF USE THEREOF LIVING PROOF, INC. 2014-01-16 US disclosed
US-8444715-B2 Coloring agents and methods of use thereof LIVING PROOF, INC. (US) 2013-05-21 US disclosed
US-20120272990-A1 COLORING AGENTS AND METHODS OF USE THEREOF LIVING PROOF, INC. (US) 2012-11-01 US disclosed
US-8187340-B2 Coloring agents and methods of use thereof LIVING PROOF, INC. (US) 2012-05-29 US disclosed
US-20110154583-A1 COLORING AGENTS AND METHODS OF USE THEREOF LIVING PROOF, INC. (US) 2011-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120272990-A1 COLORING AGENTS AND METHODS OF USE THEREOF MPO, HLA-C, ADH7 CYP1A2 1159/4885CTRB1 313/4885THRB 4668/4885
US-20110154583-A1 COLORING AGENTS AND METHODS OF USE THEREOF MPO, HLA-C, ADH7 CYP1A2 1159/4885CTRB1 313/4885THRB 4668/4885
US-20160106648-A1 COLORING AGENTS AND METHODS OF USE THEREOF MPO, HLA-C, ADH7 CYP1A2 1159/4885CTRB1 313/4885THRB 4668/4885
US-20140013520-A1 COLORING AGENTS AND METHODS OF USE THEREOF MPO, HLA-C, ADH7 CYP1A2 1159/4885CTRB1 313/4885THRB 4668/4885
US-20150174026-A1 COLORING AGENTS AND METHODS OF USE THEREOF MPO, HLA-C, ADH7 CYP1A2 1159/4885CTRB1 313/4885THRB 4668/4885
US-20140326269-A1 COLORING AGENTS AND METHODS OF USE THEREOF MPO, HLA-C, ADH7 CYP1A2 1159/4885CTRB1 313/4885THRB 4668/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.